CLARIVATE PLC - 8-K Filing

Clarivate completed the $600M sale of its Life Sciences and Healthcare business to Altaris on October 6, 2026. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CLVT

Read the full article at SEC EDGAR

Part of the story TriplePoint Venture Growth BDC Corp. - 8-K Filing (197 articles)

More Regulatory news